Le Lézard
Classified in: Health

Hood College Nursing Program Receives 10-Year Accreditation


FREDERICK, Md., Dec. 13, 2018 /PRNewswire-PRWeb/ -- The Hood College baccalaureate nursing program has received 10-year accreditation from the Commission on Collegiate Nursing Education (CCNE) and is now fully accredited through 2028.

"This is a wonderful accomplishment for our program and our work together to prepare the nurses of the 21st century," said Linda Kennedy, Ph.D., RN, CNE, assistant professor of nursing at Hood and chair of the department. "This means we meet the nationally recognized standards for quality in nursing education."

Hood's program received initial CCNE accreditation in 2013 when its four-year nursing degree began. To receive a full 10-year accreditation, the nursing faculty completed an extensive self-study prior to a CCNE campus visit in February 2018. In October 2018, the Bachelor of Science in Nursing program was awarded a 10-year accreditation.

Accreditation by the CCNE is intended to hold nursing programs accountable to the community interest; evaluate the success of a nursing program in achieving its mission, goals and expected outcomes; and foster continuing improvement in nursing programs and professional practice.

The CCNE is an autonomous accrediting agency that ensures the quality and integrity of baccalaureate, graduate and residency programs in nursing.

Hood College is an independent, liberal arts college, offering 32 undergraduate majors, four pre-professional programs, 17 graduate programs, two doctorates and 11 post-baccalaureate certificates. Located in historic Frederick, near Washington, D.C., Baltimore and the I-270 technology corridor, Hood gives students access to countless internships and research opportunities.

 

SOURCE Hood College


These press releases may also interest you

at 00:05
ImmunityBio, Inc. , an immunotherapy company, today announced positive overall survival results in the QUILT 3.055 study of 2nd- and 3rd-line NSCLC patients who progressed after checkpoint inhibitor therapy (pembrolizumab, nivolumab, or atezolizumab)...

at 00:05
The Insurance Institute for Highway Safety is updating its vehicle-to-vehicle front crash prevention test to address crashes that occur at higher speeds and those in which the struck vehicle is a motorcycle or large truck. Only one of the first 10...

at 00:00
Nutriessential.com recently announced its expansion into Oceania, Asia, and the Gulf. The company has been providing science-backed GMP-certified supplements in the US, Europe and Canada since 2005 and decided to expand owing to rising global demands...

24 avr 2024
Summit Clinical Research LLC ("Summit") is deeply saddened by the death of Co-Founder and Chairman Dr. Stephen Harrison. Summit mourns Dr. Harrison and extends its heartfelt condolences to his family and loved ones.   During an illustrious 30-year...

24 avr 2024
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced that the Drug...

24 avr 2024
Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of oncology, cardiovascular and metabolic, autoimmune, ophthalmology...



News published on and distributed by: